Cargando…
ORFeome Phage Display Reveals a Major Immunogenic Epitope on the S2 Subdomain of SARS-CoV-2 Spike Protein
The development of antibody therapies against SARS-CoV-2 remains a challenging task during the ongoing COVID-19 pandemic. All approved therapeutic antibodies are directed against the receptor binding domain (RBD) of the spike, and therefore lose neutralization efficacy against emerging SARS-CoV-2 va...
Autores principales: | Ballmann, Rico, Hotop, Sven-Kevin, Bertoglio, Federico, Steinke, Stephan, Heine, Philip Alexander, Chaudhry, M. Zeeshan, Jahn, Dieter, Pucker, Boas, Baldanti, Fausto, Piralla, Antonio, Schubert, Maren, Čičin-Šain, Luka, Brönstrup, Mark, Hust, Michael, Dübel, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229677/ https://www.ncbi.nlm.nih.gov/pubmed/35746797 http://dx.doi.org/10.3390/v14061326 |
Ejemplares similares
-
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
por: Schubert, Maren, et al.
Publicado: (2022) -
Long-term immune protection against SARS-CoV-2 escape variants upon a single vaccination with murine cytomegalovirus expressing the spike protein
por: Kim, Yeonsu, et al.
Publicado: (2022) -
Peptide microarrays coupled to machine learning reveal individual epitopes from human antibody responses with neutralizing capabilities against SARS-CoV-2
por: Hotop, Sven-Kevin, et al.
Publicado: (2022) -
Discovery of Leptospira spp. seroreactive peptides using ORFeome phage display
por: Ramli, Siti Roszilawati, et al.
Publicado: (2019) -
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy
por: Roth, Kristian Daniel Ralph, et al.
Publicado: (2021)